Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

USDT OPIATE ASSAY COLUMN CATALOG NO. 9000-200

K-Number: K932318 · 1993-06-15

ApplicantU.S. Drug Testing, Inc.
Decision Date1993-06-15
Product CodeDJG
Advisory CommitteeTX
DecisionSubstantially Equivalent

Device Summary

USDT OPIATE ASSAY COLUMN CATALOG NO. 9000-200 is the device name listed in this FDA 510(k) record. The listed applicant is U.S. Drug Testing, Inc.. It received FDA 510(k) clearance on 1993-06-15 under 510(k) number K932318. The device is classified under product code DJG. It was reviewed by the TX advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the USDT OPIATE ASSAY COLUMN CATALOG NO. 9000-200?

USDT OPIATE ASSAY COLUMN CATALOG NO. 9000-200 is a medical device that received FDA 510(k) clearance on 1993-06-15. The listed applicant is U.S. Drug Testing, Inc.. The 510(k) number is K932318.

When did USDT OPIATE ASSAY COLUMN CATALOG NO. 9000-200 receive FDA 510(k) clearance?

USDT OPIATE ASSAY COLUMN CATALOG NO. 9000-200 received FDA 510(k) clearance on 1993-06-15, under 510(k) number K932318.

Who is the listed applicant for USDT OPIATE ASSAY COLUMN CATALOG NO. 9000-200?

The FDA 510(k) record lists U.S. Drug Testing, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for USDT OPIATE ASSAY COLUMN CATALOG NO. 9000-200?

The FDA product code for USDT OPIATE ASSAY COLUMN CATALOG NO. 9000-200 is DJG.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITINGNCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITINGNCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDEDNCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Other records listing U.S. Drug Testing, Inc. as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K940912USDT CANNABINOID (THC) ASSAY COLUMN CATALOG NO. 9000-500K935629USDT PHENCYCLIDINE (PCP) ASSAY COLUMN CAT. NO. 9000-400K934693AMPHETAMINE TEST SYSTEMK931227USDT FLOW IMMUNOASSAY SYSTEM, MODEL 9000K930985USDT COCAINE/COCAINE METABOL ASSAY COLUMN,9000-100

Related Devices (Code: DJG)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K252684Labcorp Fentanyl Urine Visual TestMedtox Diagnostics, Inc.K250741Evidence MultiSTAT DOA Urine MultiPlexRandox Laboratories LimitedK253082LZI Buprenorphine II Enzyme ImmunoassayLin-Zhi International, Inc.K252520SEFRIA™ Hydrocodone Oral FluidImmunalysis CorporationK251972Healgen® AccuFluor Fentanyl Fluorescence Immunoassay (FIA)Test Kit - Qualitative; Healgen® Immunofluorescence Analyzer (OG-H180)Healgen Scientific,, LLCK251634LZI Fentanyl III Enzyme ImmunoassayLin-Zhi International, Inc.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑